143 related articles for article (PubMed ID: 38619312)
1. Severe flare of generalized pustular psoriasis treated with spesolimab, an IL-36-directed monoclonal antibody.
Mateeva V; Vasilev P; Gospodinova K; Gincheva V; Shahid M; Kostova P; Lukanov T; Yordanova I
J Dtsch Dermatol Ges; 2024 May; 22(5):696-699. PubMed ID: 38619312
[No Abstract] [Full Text] [Related]
2. Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis.
Burden AD
Expert Rev Clin Immunol; 2023 May; 19(5):473-481. PubMed ID: 36960829
[TBL] [Abstract][Full Text] [Related]
3. Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study.
Elewski BE; Lebwohl MG; Anadkat MJ; Barker J; Ghoreschi K; Imafuku S; Mrowietz U; Li L; Quaresma M; Thoma C; Bachelez H
J Am Acad Dermatol; 2023 Jul; 89(1):36-44. PubMed ID: 36870370
[TBL] [Abstract][Full Text] [Related]
4. Trial of Spesolimab for Generalized Pustular Psoriasis.
Bachelez H; Choon SE; Marrakchi S; Burden AD; Tsai TF; Morita A; Navarini AA; Zheng M; Xu J; Turki H; Anadkat MJ; Rajeswari S; Hua H; Vulcu SD; Hall D; Tetzlaff K; Thoma C; Lebwohl MG;
N Engl J Med; 2021 Dec; 385(26):2431-2440. PubMed ID: 34936739
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study.
Burden AD; Okubo Y; Zheng M; Thaçi D; van de Kerkhof P; Hu N; Quaresma M; Thoma C; Choon SE
Exp Dermatol; 2023 Aug; 32(8):1279-1283. PubMed ID: 37140190
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study.
Morita A; Tsai TF; Yee EYW; Okubo Y; Imafuku S; Zheng M; Li L; Quaresma M; Thoma C; Choon SE
J Dermatol; 2023 Feb; 50(2):183-194. PubMed ID: 36282833
[TBL] [Abstract][Full Text] [Related]
7. Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series.
Bellinato F; Gisondi P; Dattola A; Richetta AG; Costanzo A; Valenti M; De Simone C; Marzano AV; Zussino M; Pezzolo E; Nacca M; Pellacani G; Girolomoni G
J Eur Acad Dermatol Venereol; 2024 May; 38(5):e437-e439. PubMed ID: 38084869
[No Abstract] [Full Text] [Related]
8. Spesolimab: A Novel Treatment for Pustular Psoriasis.
Ratnarajah K; Jfri A; Litvinov IV; Netchiporouk E
J Cutan Med Surg; 2020; 24(2):199-200. PubMed ID: 32208020
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation.
Potestio L; Camela E; Cacciapuoti S; Martora F; Guerriero L; Fornaro L; Ruggiero A; Megna M
Expert Opin Drug Saf; 2023; 22(11):1003-1010. PubMed ID: 37768729
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Morita A; Strober B; Burden AD; Choon SE; Anadkat MJ; Marrakchi S; Tsai TF; Gordon KB; Thaçi D; Zheng M; Hu N; Haeufel T; Thoma C; Lebwohl MG
Lancet; 2023 Oct; 402(10412):1541-1551. PubMed ID: 37738999
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of recalcitrant generalized pustular psoriasis of pregnancy with spesolimab.
Yang C; Wang Y; Li R; Tu P; Wang R
J Dermatolog Treat; 2024 Dec; 35(1):2334791. PubMed ID: 38565205
[TBL] [Abstract][Full Text] [Related]
12. Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares in Adult Patients.
Bukhari T; Markovina M; Abduelmula A; Rankin BD; Vender R; Yeung J; Devani AR; Prajapati VH
Skin Therapy Lett; 2024 Jan; 29(1):1-4. PubMed ID: 38271532
[TBL] [Abstract][Full Text] [Related]
13. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
Hawkes JE; Visvanathan S; Krueger JG
Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
[TBL] [Abstract][Full Text] [Related]
14. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
[TBL] [Abstract][Full Text] [Related]
15. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD
Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with interleukin-17A antagonists of generalized pustular psoriasis in patients without IL36RN mutations.
Wilsmann-Theis D; Schnell LM; Ralser-Isselstein V; Bieber T; Schön MP; Hüffmeier U; Mössner R
J Dermatol; 2018 Jul; 45(7):850-854. PubMed ID: 29655177
[TBL] [Abstract][Full Text] [Related]
17. Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors.
Maçães CO; Lé AM; Torres T
J Dermatolog Treat; 2022 Nov; 33(7):2911-2918. PubMed ID: 35695278
[TBL] [Abstract][Full Text] [Related]
18. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
Bernardo D; Thaçi D; Torres T
Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
[TBL] [Abstract][Full Text] [Related]
19. [Remission of recalcitrant generalized pustular psoriasis under interleukin-36 receptor inhibitor spesolimab].
Müller VL; Kreuter A
Dermatologie (Heidelb); 2023 May; 74(5):356-359. PubMed ID: 36943426
[TBL] [Abstract][Full Text] [Related]
20. The role of IL-17 and IL-17 receptor inhibitors in the management of generalized pustular psoriasis.
Plachouri KM; Chourdakis V; Georgiou S
Drugs Today (Barc); 2019 Sep; 55(9):587-593. PubMed ID: 31584575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]